A Phase lb Dose Escalation Trial of R04929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER plus Metastatic Breast Cancer.

Category Primary study
JournalCANCER RESEARCH
Year 2012
This article has no abstract
Epistemonikos ID: f9e3abf94d029219376fbc57ebcf16df908126dc
First added on: Feb 05, 2025